FMT
CSTL icon

First Mercantile Trust’s Castle Biosciences CSTL Stock Holding History

First Mercantile Trust’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$309K Sell
4,650
-350
-7% -$24.6K 0.04% 266
2021
Q2 		$367K Buy
5,000
+1,100
+28% +$72.7K 0.04% 235
2021
Q1 		$267K Buy
+3,900
New +$293K 0.03% 327

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

First Mercantile Trust's CSTL Position: Q3 2021 in Review

First Mercantile Trust reduced its Castle Biosciences (CSTL) stake by 7% in Q3 2021, selling an estimated $24.6K and leaving 4,650 shares worth $309K. The position accounts for 0.04% of the portfolio, ranked #266.

First Mercantile Trust first reported a position in CSTL in Q1 2021 and has held it in 3 quarters since. The position peaked at $367K in Q2 2021. 188 funds tracked by Wall St. Rank hold CSTL as of Q3 2021.

  • First Mercantile Trust held 4,650 shares of Castle Biosciences worth $309K as of Q3 2021.
  • First Mercantile Trust sold 350 Castle Biosciences shares in Q3 2021, an estimated $24.6K.
  • Castle Biosciences made up 0.04% of First Mercantile Trust's portfolio in Q3 2021, its #266 holding.
  • First Mercantile Trust first reported a position in Castle Biosciences in Q1 2021 and has held it in 3 quarters since.
  • First Mercantile Trust's Castle Biosciences position peaked at $367K in Q2 2021.
  • 188 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.